| 000 | 01774 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516130918.0 | ||
| 264 | 0 | _c20130507 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2012-08-451690 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUsmani, Saad Z | |
| 245 | 0 | 0 |
_aPrognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. _h[electronic resource] |
| 260 |
_bBlood _cMar 2013 |
||
| 300 |
_a1819-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aMitchell, Alan | |
| 700 | 1 | _aWaheed, Sarah | |
| 700 | 1 | _aCrowley, John | |
| 700 | 1 | _aHoering, Antje | |
| 700 | 1 | _aPetty, Nathan | |
| 700 | 1 | _aBrown, Tracy | |
| 700 | 1 | _aBartel, Twyla | |
| 700 | 1 | _aAnaissie, Elias | |
| 700 | 1 | _avan Rhee, Frits | |
| 700 | 1 | _aBarlogie, Bart | |
| 773 | 0 |
_tBlood _gvol. 121 _gno. 10 _gp. 1819-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2012-08-451690 _zAvailable from publisher's website |
| 999 |
_c22408664 _d22408664 |
||